世界のデング熱ワクチン市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV00914)
◆英語タイトル:Global Dengue Vaccine Market Insights and Forecast to 2026
◆商品コード:QYR20NV00914
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはデング熱ワクチンの世界市場について調査・分析した資料です。種類別(CYD-TDV、DENVax・TAK-003、TetraVax-DV、TDENV PIV、V180、DNAワクチン)の市場規模、用途別(政府機関、病院、NGO)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別デング熱ワクチンの競争状況、市場シェア
・世界のデング熱ワクチン市場:種類別市場規模 2015年-2020年(CYD-TDV、DENVax・TAK-003、TetraVax-DV、TDENV PIV、V180、DNAワクチン)
・世界のデング熱ワクチン市場:種類別市場規模予測 2021年-2026年(CYD-TDV、DENVax・TAK-003、TetraVax-DV、TDENV PIV、V180、DNAワクチン)
・世界のデング熱ワクチン市場:用途別市場規模 2015年-2020年(政府機関、病院、NGO)
・世界のデング熱ワクチン市場:用途別市場規模予測 2021年-2026年(政府機関、病院、NGO)
・北米のデング熱ワクチン市場分析:米国、カナダ
・ヨーロッパのデング熱ワクチン市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのデング熱ワクチン市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のデング熱ワクチン市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのデング熱ワクチン市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):GlaxoSmithKline、Merck Sharp & Dohme、Sanofi、Takeda Pharmaceuticals、GeneOne Life Sciences、Medigen Biologics、Panacea Biotec、Sun Pharmaceutical、U.S NIH、Vabiotec
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking.
With the increasing population density and global warming, there is a rapid growth in the prevalence of dengue, especially in the tropical and subtropical regions across the world. According to the National Institute of Health, approximately 0.05 to 0.2 billion cases of dengue infections are reported annually and the mortality rate due to dengue was above 20,000. The report has identified the rapid growth in disease incidences as one of the primary factors that will fuel the growth of the dengue vaccine market in the coming years. The prevalence of dengue is present in more than 125 countries across the world and the rising prevalence of dengue will drive the market during the forecast period.

Market Analysis and Insights: Global Dengue Vaccine Market
The global Dengue Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Dengue Vaccine Scope and Market Size
Dengue Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dengue Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Dengue Vaccine market is segmented into
CYD-TDV
DENVax or TAK-003
TetraVax-DV
TDENV PIV
V180
DNA vaccines

Segment by Application, the Dengue Vaccine market is segmented into
Government institutions
Hospitals
NGOs

Regional and Country-level Analysis
The Dengue Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dengue Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dengue Vaccine Market Share Analysis
Dengue Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dengue Vaccine business, the date to enter into the Dengue Vaccine market, Dengue Vaccine product introduction, recent developments, etc.

The major vendors covered:
GlaxoSmithKline
Merck Sharp & Dohme
Sanofi
Takeda Pharmaceuticals
GeneOne Life Sciences
Medigen Biologics
Panacea Biotec
Sun Pharmaceutical
U.S NIH
Vabiotec

【レポートの目次】

1 Study Coverage
1.1 Dengue Vaccine Product Introduction
1.2 Market Segments
1.3 Key Dengue Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dengue Vaccine Market Size Growth Rate by Type
1.4.2 CYD-TDV
1.4.3 DENVax or TAK-003
1.4.4 TetraVax-DV
1.4.5 TDENV PIV
1.4.6 V180
1.4.7 DNA vaccines
1.5 Market by Application
1.5.1 Global Dengue Vaccine Market Size Growth Rate by Application
1.5.2 Government institutions
1.5.3 Hospitals
1.5.4 NGOs
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Dengue Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Dengue Vaccine Revenue 2015-2026
2.1.2 Global Dengue Vaccine Sales 2015-2026
2.2 Global Dengue Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dengue Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dengue Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Dengue Vaccine Competitor Landscape by Players
3.1 Dengue Vaccine Sales by Manufacturers
3.1.1 Dengue Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Dengue Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Dengue Vaccine Revenue by Manufacturers
3.2.1 Dengue Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Dengue Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dengue Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dengue Vaccine Revenue in 2019
3.2.5 Global Dengue Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dengue Vaccine Price by Manufacturers
3.4 Dengue Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Dengue Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dengue Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Dengue Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Dengue Vaccine Market Size by Type (2015-2020)
4.1.1 Global Dengue Vaccine Sales by Type (2015-2020)
4.1.2 Global Dengue Vaccine Revenue by Type (2015-2020)
4.1.3 Dengue Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dengue Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Dengue Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Dengue Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Dengue Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dengue Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Dengue Vaccine Market Size by Application (2015-2020)
5.1.1 Global Dengue Vaccine Sales by Application (2015-2020)
5.1.2 Global Dengue Vaccine Revenue by Application (2015-2020)
5.1.3 Dengue Vaccine Price by Application (2015-2020)
5.2 Dengue Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Dengue Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Dengue Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Dengue Vaccine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Dengue Vaccine by Country
6.1.1 North America Dengue Vaccine Sales by Country
6.1.2 North America Dengue Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dengue Vaccine Market Facts & Figures by Type
6.3 North America Dengue Vaccine Market Facts & Figures by Application

7 Europe
7.1 Europe Dengue Vaccine by Country
7.1.1 Europe Dengue Vaccine Sales by Country
7.1.2 Europe Dengue Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dengue Vaccine Market Facts & Figures by Type
7.3 Europe Dengue Vaccine Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Dengue Vaccine by Region
8.1.1 Asia Pacific Dengue Vaccine Sales by Region
8.1.2 Asia Pacific Dengue Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dengue Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Dengue Vaccine Market Facts & Figures by Application

9 Latin America
9.1 Latin America Dengue Vaccine by Country
9.1.1 Latin America Dengue Vaccine Sales by Country
9.1.2 Latin America Dengue Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dengue Vaccine Market Facts & Figures by Type
9.3 Central & South America Dengue Vaccine Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Dengue Vaccine by Country
10.1.1 Middle East and Africa Dengue Vaccine Sales by Country
10.1.2 Middle East and Africa Dengue Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dengue Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Dengue Vaccine Market Facts & Figures by Application

11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Merck Sharp & Dohme
11.2.1 Merck Sharp & Dohme Corporation Information
11.2.2 Merck Sharp & Dohme Description and Business Overview
11.2.3 Merck Sharp & Dohme Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Sharp & Dohme Dengue Vaccine Products Offered
11.2.5 Merck Sharp & Dohme Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description and Business Overview
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Dengue Vaccine Products Offered
11.3.5 Sanofi Related Developments
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Corporation Information
11.4.2 Takeda Pharmaceuticals Description and Business Overview
11.4.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Takeda Pharmaceuticals Dengue Vaccine Products Offered
11.4.5 Takeda Pharmaceuticals Related Developments
11.5 GeneOne Life Sciences
11.5.1 GeneOne Life Sciences Corporation Information
11.5.2 GeneOne Life Sciences Description and Business Overview
11.5.3 GeneOne Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GeneOne Life Sciences Dengue Vaccine Products Offered
11.5.5 GeneOne Life Sciences Related Developments
11.6 Medigen Biologics
11.6.1 Medigen Biologics Corporation Information
11.6.2 Medigen Biologics Description and Business Overview
11.6.3 Medigen Biologics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Medigen Biologics Dengue Vaccine Products Offered
11.6.5 Medigen Biologics Related Developments
11.7 Panacea Biotec
11.7.1 Panacea Biotec Corporation Information
11.7.2 Panacea Biotec Description and Business Overview
11.7.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Panacea Biotec Dengue Vaccine Products Offered
11.7.5 Panacea Biotec Related Developments
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Corporation Information
11.8.2 Sun Pharmaceutical Description and Business Overview
11.8.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sun Pharmaceutical Dengue Vaccine Products Offered
11.8.5 Sun Pharmaceutical Related Developments
11.9 U.S NIH
11.9.1 U.S NIH Corporation Information
11.9.2 U.S NIH Description and Business Overview
11.9.3 U.S NIH Sales, Revenue and Gross Margin (2015-2020)
11.9.4 U.S NIH Dengue Vaccine Products Offered
11.9.5 U.S NIH Related Developments
11.10 Vabiotec
11.10.1 Vabiotec Corporation Information
11.10.2 Vabiotec Description and Business Overview
11.10.3 Vabiotec Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Vabiotec Dengue Vaccine Products Offered
11.10.5 Vabiotec Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
11.1.5 GlaxoSmithKline Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dengue Vaccine Market Estimates and Projections by Region
12.1.1 Global Dengue Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Dengue Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Dengue Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Dengue Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Dengue Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Dengue Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Dengue Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Dengue Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Dengue Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Dengue Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dengue Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dengue Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dengue Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dengue Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Dengue Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Dengue Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Dengue Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Dengue Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dengue Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dengue Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dengue Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dengue Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dengue Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dengue Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

GlaxoSmithKline、Merck Sharp & Dohme、Sanofi、Takeda Pharmaceuticals、GeneOne Life Sciences、Medigen Biologics、Panacea Biotec、Sun Pharmaceutical、U.S NIH、Vabiotec

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のデング熱ワクチン市場2026:インサイト・予測(Global Dengue Vaccine Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。